"Feluda" India's First Low cost Covid 19 Test

⇨The country is fighting against COVID 19 pandemic and currently COVID 19 testing has also been increased. There has been good news during this time. Tata Group and CSIR-IGIB developed DCGI(Drug Controller General of India) approved India's first CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats) COVID 19 test.

⇨Tata Group has worked with CSIR-IGIB and ICMR to create a high quality test that will help the country to increase COVID 19 testing very quickly and economically.

⇨The release said, "This test uses an indigenously developed, cutting edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus. CRISPR is genome editing technology to diagnosing diseases. The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID 19. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests, with quicker turnaround time, less expensive equipment, and better ease of use. Moreover, CRISPR is a futuristic technology that can also be configured for the detection of multiple other pathogens in the future. "

⇨According to the release, Tata group has worked with CSIR-IGBI and ICMR in the direction of 'Made in India' to develop a high quality test that is reliable, affordable and easily available that will help to increase the country' COVID 19 testing.